Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy
- Conditions
- Peripheral Neuropathy
- First Posted Date
- 2012-02-02
- Last Posted Date
- 2018-02-28
- Lead Sponsor
- JFK Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT01524666
- Locations
- 🇺🇸
JFK Medical Center, Edison, New Jersey, United States
Effectiveness of Amantadine Hydrochloride for Treatment of Severe Traumatic Brain Injury (TBI)
Phase 2
Completed
- Conditions
- Traumatic Brain Injury
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-09-03
- Last Posted Date
- 2012-09-24
- Lead Sponsor
- JFK Medical Center
- Target Recruit Count
- 184
- Registration Number
- NCT00970944
- Locations
- 🇺🇸
Braintree Rehabilitation Hospital, Braintree, Massachusetts, United States
🇺🇸Methodist Rehabilitation Center, Jackson, Mississippi, United States
🇺🇸Columbia University, New York, New York, United States
News
No news found